CRTh2 antagonist 1

CAS No. 1379445-54-1

CRTh2 antagonist 1( —— )

Catalog No. M32744 CAS No. 1379445-54-1

CRTh2 antagonist 1 is a CRTh2 antagonist [IC50: 89 nM].

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 282 In Stock
5MG 255 In Stock
10MG 374 In Stock
25MG 562 In Stock
50MG 770 In Stock
100MG 1051 In Stock
200MG Get Quote In Stock
500MG 2102 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CRTh2 antagonist 1
  • Note
    Research use only, not for human use.
  • Brief Description
    CRTh2 antagonist 1 is a CRTh2 antagonist [IC50: 89 nM].
  • Description
    CRTh2 antagonist 1 is a CRTh2 antagonist with an IC50 of 89 nM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    GPR
  • Recptor
    GPR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1379445-54-1
  • Formula Weight
    455.53
  • Molecular Formula
    C23H25N3O5S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(C(O)=O)C=1C(=NN(CC2=C(S(=O)(=O)N3CCOCC3)C=CC=C2)C1C)C4=CC=CC=C4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Andrés M, et al. 2-(1H-Pyrazol-4-yl)acetic acids as CRTh2 antagonists. Bioorg Med Chem Lett. 2013 Jun 1;23(11):3349-53.?
molnova catalog
related products
  • Grp94 Inhibitor-1

    Grp94 Inhibitor-1 is a potent selective Grp94 inhibitor (IC50 : 2 nM).?

  • 3-chloro-5-hydroxybe...

    3-chloro-5-hydroxy Benzoic Acid (3-chloro-5-hydroxy BA) is an agonist of GPR81 (EC50 : 16 μM).

  • GPR81 agonist 1

    GPR81 agonist 1 is a potent and selective GPR81 agonist with high affinity for human and mouse GPR81, inhibiting lipolysis of differentiated 3T3-L1 adipocytes, improving insulin sensitivity and glycaemic control in mouse models of insulin resistance and diabetes, and can be used in the study of diabetes and obesity.